Wu J, Gu J, Xu J, Wang J, Sun Z, Smirnov M D, Morrissey J H, Esmon N
Anhui Provincial Hospital, Hefei 230001, China.
Chin Med J (Engl). 2001 Apr;114(4):379-81.
To investigate the factor V Leiden mutation associated with activated protein C resistance (APCR) in Chinese.
Thirty "normal" individuals and twenty patients with thrombotic disease from Chinese Han Nationality were studied with APTT +/- APC, PCR followed by MnLI restriction enzyme analysis, PCR based direct sequence-specific primers (PCR-SSP) and DNA sequence analysis.
In one healthy control, the activated protein C (APC) sensitivity ratio (SR) was found to be significantly lower (0.8) than that in other normal control (> 2.0). This individual was identified to be heterozygous for FV Leiden mutation (Arg506-Gln). His grand-uncle, father, brother and son were also identified to be heterozygous for FV Leiden. The APC resistance was found in 3 other cases of thrombotic diseases, but with no FV Leiden mutation.
This is the first four generations family case of FV Leiden mutation associated with APCR reported within Chinese ethnic population. It is note-worthy that more FV Leiden or whether other gene defects may be associated with APC resistance and acquired APCR causing thrombosis in Chinese population.
研究中国人群中与活化蛋白C抵抗(APCR)相关的凝血因子V莱顿突变。
采用APTT±活化蛋白C(APC)、PCR后用MnLI限制性内切酶分析、基于PCR的直接序列特异性引物(PCR-SSP)及DNA序列分析,对30名中国汉族“正常”个体和20名血栓性疾病患者进行研究。
在一名健康对照者中,发现活化蛋白C(APC)敏感率(SR)显著低于其他正常对照者(0.8对比>2.0)。该个体被鉴定为凝血因子V莱顿突变(Arg506-Gln)杂合子。其叔祖父、父亲、兄弟和儿子也被鉴定为凝血因子V莱顿杂合子。在另外3例血栓性疾病患者中发现了APC抵抗,但未发现凝血因子V莱顿突变。
这是中国人群中首次报道的与APCR相关的凝血因子V莱顿突变的四代家族病例。值得注意的是,在中国人群中是否有更多的凝血因子V莱顿突变或其他基因缺陷可能与APC抵抗及获得性APCR导致血栓形成有关。